The prognostic value of GDF15 for systemic cardiovascular events in patients with atherosclerotic cardiovascular disease including CAD and CVD has also been previously demonstrated in an individual patient-level meta-analysis by Kato et al. (2023) [46]. This evidence concerns the gene GDF15 and coronary artery disorder.